ロード中...
Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver disease worldwide. NAFLD progresses in some cases to non-alcoholic steatohepatitis (NASH), which is characterized, in addition to liver fat deposition, by hepatocyte ballooning, inflammation and liver fibrosis, and i...
保存先:
| 出版年: | World J Hepatol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475780/ https://ncbi.nlm.nih.gov/pubmed/32952876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v12.i8.493 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|